marketnews

Edwards Lifesciences (EW) Faces Investor Class Action After Losing Over $16 Billion in Market Capitalization: A Professional and Reader-Friendly Rewrite

Hagens Berman Urges Edwards Lifesciences Corporation Investors to Submit Losses Class Action Lawsuit Details Class Period: Feb. 6, 2024 – July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Hagens Berman, a leading national securities fraud law firm, is urging investors of Edwards Lifesciences Corporation (NYSE: EW) who have suffered substantial losses to submit their…

Read More

Unlocking the Power of PTF Technology: A Comprehensive Dashboard for November

Industry Metrics in the Information Technology Sector Introduction According to recent reports, the information technology sector is currently the second most overvalued GICS sector in the market. Within this sector, semiconductors and hardware stand out as the most overvalued subsectors. Despite this, the Invesco DWA Technology Momentum ETF (PTF) has shown significant outperformance compared to…

Read More

Transaction in Own Shares: A Professional, Educated, and Profit-Focused Update

Shell plc Announces Purchase of Shares for Cancellation Transaction in Own Shares 18 November, 2024 Shell plc (the ‘Company’) has announced that on 18 November 2024, it purchased a substantial number of Shares for cancellation. The shares were bought at various prices on different trading venues, as detailed below: Aggregated information on Shares purchased according…

Read More

New Data on Terlivaz (Terlipressin) for Hepatorenal Syndrome Presented at AASLD Annual Meeting 2024 by Mallinckrodt Pharmaceuticals

Mallinckrodt plc Announces Poster Presentation on TERLIVAZ® at The Liver Meeting DUBLIN, Nov. 18, 2024 /PRNewswire/ — Mallinckrodt plc, a global specialty pharmaceutical company, presented a poster on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function at The Liver Meeting, the annual meeting of the American Association…

Read More

Breaking Boundaries: One World Products Pioneers Sustainable Solutions Through Revolutionary Hemp Innovations

Welcome to the Future of Eco-Friendly Materials One World Products, Inc. Leading the Charge in Industrial Hemp Market LAS VEGAS, Nov. 18, 2024 (GLOBE NEWSWIRE) — One World Products, Inc. (“OWP”) (OTCQB: OWPC) is making waves in the industrial hemp market with its innovative approach to eco-friendly materials. The company has recently announced significant progress,…

Read More

Regenxbio Launches Pivotal Phase of Affinity Duchenne Trial for RGX-202 Gene Therapy with Positive Functional Results

Regenxbio Launches Pivotal Phase of Affinity Duchenne Trial for RGX-202 Gene Therapy with Positive Functional Results Description: Alignment achieved with FDA on AFFINITY DUCHENNE® pivotal program and access to accelerated approval; BLA expected in 2026. Pivotal trial of RGX-202 is enrolling ambulatory patients aged 1 and above with the first patient dosed. Phase I/II data…

Read More